Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00607776 | Artificial Tears Study in Mild to Moderate Dry Eye Patients | PHASE2 | COMPLETED | 110 | — | — | Jan 1, 2007 | Apr 1, 2007 | Feb 3, 2025 | - | — |
| Arm | Type | Description |
|---|---|---|
| 1 | ACTIVE_COMPARATOR | Systane |
| 2 | EXPERIMENTAL | Blink tears |
| Name | Type | Description |
|---|---|---|
| (9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400 | DRUG | Drops |
| Systane | DRUG | Drops |
Inclusion Criteria: * Mild to moderate dry eye * over 18 Exclusion Criteria: * No concurrent ocular disease or meds